Overview

Ocular Allergy Treatment Practical Impact Trial

Status:
Unknown status

Trial end date:
2013-11-01

Target enrollment:

Participant gender:

Summary

To study the impact of alcaftadine in patients treated with other opthalmic ocular agents (or specific topical opthalmic treatment) in an allergy subspecialist outpatient setting.

Phase:

Phase 4

Details

Lead Sponsor:

Starx Research Center, LLC

Treatments:

Alcaftadine